CHAM
ORIC icon

Clear Harbor Asset Management’s Oric Pharmaceuticals ORIC Stock Holding History

Clear Harbor Asset Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,119
Closed -$181K – 470
2025
Q3 		$181K Hold
15,119
– – 0.01% 396
2025
Q2 		$153K Hold
15,119
– – 0.01% 390
2025
Q1 		$84.4K Buy
15,119
+1,375
+10% +$12K 0.01% 392
2024
Q4 		$111K Hold
13,744
– – 0.01% 372
2024
Q3 		$141K Hold
13,744
– – 0.01% 349
2024
Q2 		$97.2K Hold
13,744
– – 0.01% 350
2024
Q1 		$189K Buy
+13,744
New +$163K 0.02% 338

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clear Harbor Asset Management's ORIC Position: Q4 2025 in Review

Clear Harbor Asset Management sold out of Oric Pharmaceuticals (ORIC) in Q4 2025, closing a stake of 15,119 shares — an estimated $181K sold.

Clear Harbor Asset Management first reported a position in ORIC in Q1 2024 and held it in 7 quarters. The position peaked at $189K in Q1 2024. 164 funds tracked by Wall St. Rank hold ORIC as of Q4 2025.

  • Clear Harbor Asset Management reported no remaining Oric Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Clear Harbor Asset Management sold 15,119 Oric Pharmaceuticals shares in Q4 2025, an estimated $181K.
  • Clear Harbor Asset Management first reported a position in Oric Pharmaceuticals in Q1 2024 and held it in 7 quarters.
  • Clear Harbor Asset Management's Oric Pharmaceuticals position peaked at $189K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q4 2025.

Based on Clear Harbor Asset Management's 13F filing for Q4 2025, filed 10 Feb 2026.